Toivo Maimets

1.3k citations
51 papers · 1.0k indexed · h-index 17
Topics
Cancer-related Molecular Pathways (14 papers)RNA modifications and cancer (8 papers)RNA and protein synthesis mechanisms (7 papers)
Partner nations
EstoniaLatviaNorway

In The Last Decade

Toivo Maimets

48 papers receiving 1.0k citations

Peers

Toivo Maimets
Comparison fields: 5 of 103
  • Molecular Biology 717
  • Oncology 373
  • Cancer Research 129
  • Genetics 118
  • Immunology 85
Replace Jirouta Kitagaki with:
Jirouta Kitagaki Japan
Friederike Herbst Germany
Susan Fosmire United States
Danuta Balicki United States
Joelle M. Fenger United States
Lucy T.C. Peltenburg Netherlands
Ines Eue Germany
Roberta Ceruti Italy
Steven A. Maxwell United States
Jay S. Lillquist United States
Toivo Maimets relative to Jirouta Kitagaki Japan Jirouta Kitagaki's profile →
Citations per field
00.5×1.5×
Jirouta Kitagaki · 1×
Citations per year

Countries citing papers authored by Toivo Maimets

Since Specialization
Citations

This map shows the geographic impact of Toivo Maimets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toivo Maimets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toivo Maimets more than expected).

Fields of papers citing papers by Toivo Maimets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toivo Maimets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toivo Maimets. The network helps show where Toivo Maimets may publish in the future.

Co-authorship network of co-authors of Toivo Maimets

This figure shows the co-authorship network connecting the top 25 collaborators of Toivo Maimets. A scholar is included among the top collaborators of Toivo Maimets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toivo Maimets. Toivo Maimets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 6
3 6
4 3
5 23
6 6
7 22
8 7
9 5
10 39
11 6
12 9
13 109
14 90
15 17
16 9
17 30
18 15
19 11
20 11

About Toivo Maimets

Toivo Maimets is a scholar working on Oncology, Molecular Biology and Biological Psychiatry, having authored 51 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (14 papers), RNA modifications and cancer (8 papers) and RNA and protein synthesis mechanisms (7 papers). The work is most often cited by research in Oncology (373 citations), Molecular Biology (717 citations) and Biotechnology (79 citations). Toivo Maimets has collaborated with scholars based in Estonia, Latvia and Norway. Frequent co-authors include Arnold Kristjuhan, Viljar Jaks, Irina Neganova, Lyle Armstrong, Majlinda Lako, Martin Pook, Ruth Brain, Christine M. Addison, K. Rudge and Mart Ustav. Their work appears in journals such as PLoS ONE, Analytical Biochemistry and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026